V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250011944 | 250007704 | 1.77 | 77 | Palliative (P) | 2012-10-20 | 2013-04-20 | VINORELBINE | N | N | 250030336 | VINORELBINE |
| 250011945 | 250007706 | null | 100 | Palliative (P) | 2016-10-13 | 2018-01-11 | Cisplatin + Pemetrexed | N | N | 250030341 | CISPLATIN + PEMETREXED |
| 250011946 | 250007708 | null | null | Palliative (P) | 2017-06-11 | 2017-06-11 | Vinorelbine (oral) | 2 | N | 250030354 | VINORELBINE |
| 250011947 | 250007715 | 1.77 | 65.5 | Curative (C) | 2015-08-22 | 2016-04-29 | RUXOLITINIB | N | N | 250030394 | RUXOLITINIB |
| 250011949 | 250007718 | 1.76 | 55.8 | Palliative (P) | 2017-03-16 | 2017-03-16 | Vinorelbine IV | 02 | N | 250030421 | VINORELBINE |
| 250011950 | 250007720 | 1.76 | 72.2 | Palliative (P) | 2017-06-26 | 2017-08-24 | Cisplatin + Pemetrexed | N | N | 250030449 | CISPLATIN + PEMETREXED |
| 250011951 | 250012586 | null | null | null | 2018-01-19 | 2018-02-11 | CHOP R - 21 days | null | null | 250030482 | AZACITIDINE |
| 250011952 | 250010870 | 1.65 | 58.8 | Palliative (P) | 2017-04-13 | 2017-04-25 | Rituximab | null | N | 250030505 | RITUXIMAB |
| 250011953 | 250007723 | 1.76 | 130 | Disease modification (D) | null | 2016-07-03 | ANAGRELIDE | N | N | 250030507 | AZACITIDINE |
| 250011954 | 250007726 | 1.73 | null | Disease modification (D) | 2017-12-17 | 2017-12-18 | Rituximab | null | N | 250030520 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250011955 | 250007729 | null | null | Palliative (P) | 2015-09-26 | 2015-09-26 | CHOP R - 21 days | N | N | 250030531 | BENDAMUSTINE + RITUXIMAB |
| 250011956 | 250007731 | 1.67 | null | Disease modification (D) | 2019-04-04 | 2019-04-10 | Carboplatin + Vinorelbine IV | null | null | 250030535 | DASATINIB |
| 250011957 | 250010874 | null | null | Disease modification (D) | 2017-06-02 | 2017-09-24 | MELPHALAN | 02 | N | 250030536 | ANAGRELIDE |
| 250011958 | 250007733 | 1.44 | 53 | Disease modification (D) | 2013-07-29 | 2015-05-30 | ANAGRELIDE | 02 | N | 250030550 | RITUXIMAB |
| 250011959 | 250007736 | null | 77.7 | Disease modification (D) | 2016-10-18 | 2016-10-18 | HLH | N | N | 250030607 | PEG INTERFERON |
| 250011960 | 250007742 | null | null | Disease modification (D) | 2015-08-26 | 2015-08-26 | BUSULFAN | null | N | 250030659 | ANAGRELIDE |
| 250011961 | 250012106 | 1.71 | 89 | Disease modification (D) | 2012-11-09 | 2014-03-24 | BUSULFAN | null | N | 250030681 | NOT MATCHED |
| 250011962 | 250007744 | 1.76 | null | Palliative (P) | 2014-03-18 | 2016-02-03 | ANAGRELIDE | N | N | 250030683 | ANAGRELIDE |
| 250011963 | 250007746 | null | null | Adjuvant (A) | 2018-02-14 | 2018-03-17 | MELPHALAN | 01 | null | 250030701 | NILOTINIB |
| 250011964 | 250007748 | null | null | Palliative (P) | 2018-01-18 | 2018-06-07 | GemCarbo Days 1+8 | 02 | N | 250030717 | AZACITIDINE |
| 250011965 | 250007749 | null | null | Disease modification (D) | 2013-07-18 | 2013-07-18 | IPM | 2 | null | 250030720 | IRINOTECAN + MDG |
| 250011966 | 250007754 | null | null | null | 2016-04-05 | 2016-04-06 | CHLORAMBUCIL + OFATUMUMAB | 2 | N | 250030761 | VEPEMB |
| 250011967 | 250007757 | 1.74 | 76.2 | Palliative (P) | 2017-08-15 | 2017-08-22 | Nilotinib | null | N | 250030776 | IMATINIB |
| 250011968 | 250007759 | 1.67 | 75.6 | Palliative (P) | null | 2015-10-29 | ATG + Busulfan + Fludarabine | Y | N | 250030794 | ALL MAINTENANCE |
| 250011969 | 250007763 | 1.52 | 81.8 | Palliative (P) | 2018-12-27 | 2018-12-31 | ANAGRELIDE | 02 | N | 250030817 | FLUDARABINE + MELPHALAN |
| 250011971 | 250007769 | 1.69 | 64.1 | Palliative (P) | 2016-11-28 | 2016-12-10 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 250030842 | BUSULPHAN |
| 250011972 | 250007771 | null | null | Palliative (P) | 2013-09-20 | 2014-01-07 | Carboplatin AUC 2 - 5 | null | N | 250030853 | DA |
| 250011973 | 250007772 | null | 0 | Palliative (P) | 2017-06-19 | 2017-07-29 | IMATINIB | 02 | N | 250030855 | ANAGRELIDE |
| 250011974 | 250007776 | null | 49.7 | Palliative (P) | 2016-08-25 | 2016-08-25 | Carboplatin AUC 2 - 5 | null | N | 250030856 | FLAG + IDARUBICIN |
| 250011975 | 250007779 | 1.72 | 71 | Palliative (P) | 2016-03-22 | 2016-03-26 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 2 | N | 250030868 | MITOXANTRONE |
| 250011976 | 250007781 | null | 69.5 | Palliative (P) | 2014-09-09 | 2014-09-15 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 01 | N | 250030911 | AZACITIDINE |
| 250011977 | 250007782 | 0 | 75.4 | Palliative (P) | 2012-06-15 | 2013-10-27 | Busulfan Oral | N | N | 250030913 | CYCLOPHOSPHAMIDE |
| 250011978 | 250007784 | 1.56 | 94.45 | Palliative (P) | 2016-11-13 | 2016-11-20 | BUSULFAN | Y | N | 250030916 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250011979 | 250007786 | 1.68 | 87.1 | Palliative (P) | 2014-03-24 | 2015-02-11 | GemCarbo Days 1+8 | 02 | Y | 250030917 | NOT MATCHED |
| 250011980 | 250010894 | 1.64 | 67.6 | Palliative (P) | 2015-06-13 | 2015-06-20 | Liposomal Doxorubicin 50mg/m2 | 2 | N | 250030918 | TEMOZOLOMIDE |
| 250011981 | 250007797 | 0 | 92.2 | Palliative (P) | 2017-03-02 | 2017-03-06 | CISPLATIN + FLUOROURACIL | 2 | N | 250030979 | PONATINIB |
| 250011982 | 250010896 | 1.74 | 72 | Palliative (P) | 2018-01-28 | 2018-11-24 | GemCarbo Days 1+8 | N | N | 250031012 | PEMETREXED |
| 250011983 | 250010897 | null | 84 | Palliative (P) | 2017-10-16 | 2017-11-14 | GemCarbo Days 1+8 | 99 | null | 250031023 | GEMCARBO |
| 250011984 | 250007800 | 1.8 | 91.5 | Palliative (P) | 2013-06-21 | 2014-01-28 | PEG INTERFERON | 02 | N | 250031024 | GEMCARBO |
| 250011985 | 250007802 | 1.72 | null | Palliative (P) | null | 2016-10-26 | GemCarbo Days 1+8 | 2 | N | 250031033 | CARBOPLATIN |
| 250011987 | 250007806 | 1.59 | 75 | Palliative (P) | 2014-08-15 | 2014-08-22 | Cytarabine High Dose | 2 | N | 250031086 | BEVACIZUMAB |
| 250011988 | 250007809 | 1.58 | 92.6 | Palliative (P) | 2015-07-06 | 2015-07-13 | Temozolomide 200mg/m2 | Y | N | 250031099 | GEMCARBO |
| 250011989 | 250007810 | 1.72 | 86 | Disease modification (D) | 2016-01-03 | 2016-03-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250031118 | CARBOPLATIN |
| 250011990 | 250007812 | 1.85 | 62.5 | Palliative (P) | 2018-01-18 | 2018-01-26 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 250031129 | CAPECITABINE |
| 250011991 | 250007813 | 1.74 | 88 | Palliative (P) | 2014-05-01 | 2014-05-20 | Abiraterone | 1 | N | 250031159 | GEMCARBO |
| 250011992 | 250010908 | 1.74 | 0 | Palliative (P) | 2014-03-03 | 2014-03-12 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | 250031196 | NOT MATCHED |
| 250011993 | 250007818 | 0 | 49.8 | Palliative (P) | 2015-11-21 | 2016-01-30 | Pemetrexed | N | N | 250031205 | CARBOPLATIN + VINORELBINE |
| 250011994 | 250010910 | 1.65 | 85 | Palliative (P) | 2016-06-24 | 2016-06-30 | Carboplatin + Vinorelbine Oral | N | N | 250031210 | PEMETREXED |
| 250011995 | 250007823 | 1.73 | 95.7 | Palliative (P) | 2017-03-25 | 2017-05-05 | Carboplatin + Vinorelbine IV | 02 | N | 250031247 | IPM |
| 250011996 | 250007826 | null | 60.5 | Curative (C) | 2017-09-05 | 2017-09-19 | Carboplatin + Etoposide IV 3 day | N | null | 250031257 | CARBOPLATIN + PACLITAXEL |